文献
J-GLOBAL ID:201802268449937585
整理番号:18A0329544
ceritinibにおける末端ピペリジンの置換脂肪族アミンによるG1202R含むクリゾチニブ耐性変異株に対する活性を付与する【Powered by NICT】
Replacing the terminal piperidine in ceritinib with aliphatic amines confers activities against crizotinib-resistant mutants including G1202R
著者 (27件):
Mathi Gangadhar Rao
(Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon 34114, South Korea)
,
Mathi Gangadhar Rao
(Department of Medicinal Chemistry and Pharmacology, University of Science & Technology, Daejeon 34113, South Korea)
,
Kang Chung Hyo
(Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon 34114, South Korea)
,
Kang Chung Hyo
(College of Pharmacy, Chungnam National University, Daejeon 34134, South Korea)
,
Lee Heung Kyoung
(Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon 34114, South Korea)
,
Achary Raghavendra
(Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon 34114, South Korea)
,
Achary Raghavendra
(Department of Medicinal Chemistry and Pharmacology, University of Science & Technology, Daejeon 34113, South Korea)
,
Lee Ha-Yeon
(Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon 34114, South Korea)
,
Lee Ha-Yeon
(College of Pharmacy, Chungbuk National University, Cheongju 28644, South Korea)
,
Lee Joo-Youn
(Korea Chemical Bank, Korea Research Institute of Chemical Technology, Daejeon 34114, South Korea)
,
Ha Jae Du
(Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon 34114, South Korea)
,
Ahn Sunjoo
(Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon 34114, South Korea)
,
Ahn Sunjoo
(Department of Medicinal Chemistry and Pharmacology, University of Science & Technology, Daejeon 34113, South Korea)
,
Park Chi Hoon
(Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon 34114, South Korea)
,
Park Chi Hoon
(Department of Medicinal Chemistry and Pharmacology, University of Science & Technology, Daejeon 34113, South Korea)
,
Lee Chong Ock
(Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon 34114, South Korea)
,
Hwang Jong Yeon
(Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon 34114, South Korea)
,
Hwang Jong Yeon
(Department of Medicinal Chemistry and Pharmacology, University of Science & Technology, Daejeon 34113, South Korea)
,
Yun Chang-Soo
(Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon 34114, South Korea)
,
Yun Chang-Soo
(Department of Medicinal Chemistry and Pharmacology, University of Science & Technology, Daejeon 34113, South Korea)
,
Jung Hee Jung
(Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon 34114, South Korea)
,
Jung Hee Jung
(Department of Medicinal Chemistry and Pharmacology, University of Science & Technology, Daejeon 34113, South Korea)
,
Cho Sung Yun
(Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon 34114, South Korea)
,
Cho Sung Yun
(Department of Medicinal Chemistry and Pharmacology, University of Science & Technology, Daejeon 34113, South Korea)
,
Kim Hyoung Rae
(Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon 34114, South Korea)
,
Kim Pilho
(Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon 34114, South Korea)
,
Kim Pilho
(Department of Medicinal Chemistry and Pharmacology, University of Science & Technology, Daejeon 34113, South Korea)
資料名:
European Journal of Medicinal Chemistry
(European Journal of Medicinal Chemistry)
巻:
126
ページ:
536-549
発行年:
2017年
JST資料番号:
E0845A
ISSN:
0223-5234
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)